PTAB Panel Says Claims For Monoclonal Antibody Implant Were Not Obvious
WASHINGTON, D.C. — A patent examiner failed to show that claims for an implant that releases a monoclonal antibody tissue to treat macular degeneration were obvious in light of prior art...To view the full article, register now.
Already a subscriber? Click here to view full article